Which ASX Small Cap Wins 2026? Six Tech Categories Say Scalare Partners Belongs in the Conversation
Ask a room of small-cap investors which ASX name wins 2026 and you will hear the usual suspects. Ask which one holds 27 early-stage technology companies across six categories and has 360% revenue growth lodged with the exchange, and the room goes quiet. That is the gap Scalare Partners (ASX: SCP) sits in.
As at 31 December 2025 the portfolio spans fintech, healthtech, regtech, cleantech, SaaS and AI: 27 companies, one ticker, sourced from the founder communities Scalare operates, including Tank Stream Labs and Fishburners. Named holdings include WithU, MyPass, CHI and Zondii.
Six categories through one share is exposure most Australians have never been able to buy. Venture funds sell it to institutions with minimums and lock-ups. Scalare put it on the ASX. Shares are traded on the ASX, subject to market liquidity.
Revenue and other income up 360% on the prior corresponding period for the half-year to 31 December 2025, per the Appendix 4D lodged with the ASX on 27 February 2026. Includes revenue from businesses acquired during the period; growth was materially acquisition-driven, with Tank Stream Labs around 73% of service revenue. Past performance is not a reliable indicator of future performance. The full filing is on the ASX announcements platform under SCP.
The number is lodged. The portfolio is disclosed. The model is public. The only thing that is not yet crowded is the attention. In small caps, that is the whole trade.
Read the free investor brief. Every figure in it ties back to the filing on the ASX announcements platform.
Paid advertisement — disclosure
Paid advertisement by SGNL Media, engaged by Fairfax Partners Inc. on behalf of Scalare Partners Holdings Limited (ASX: SCP). Compensation for this promotion is cash only. No securities, options or performance-linked consideration form part of that compensation.
Neither SGNL Media nor Fairfax Partners Inc. holds securities in the company. They are paid to communicate information about the company and do not benefit directly from movements in its share price.
This article is general information only and is not financial advice. It does not take into account your objectives, financial situation or needs. Investing in shares involves risk, including the possible loss of capital. Review the company's complete ASX disclosures and consider obtaining advice from an appropriately licensed financial adviser before making an investment decision.
